Results 1 to 10 of about 167,841 (160)

The treatment of epithelial ovarian cancer [PDF]

Ca-A Cancer Journal for Clinicians, 1995
The treatment and long-term survival of patients with ovarian cancer varies by stage. At present, five-year survival for patients with early-stage disease ranges from 50 to 95 percent, while five-year survival for patients with advanced-stage disease is less than 25 percent.
William P Mcguire
exaly   +3 more sources

Epithelial Ovarian Cancer [PDF]

Journal of the National Comprehensive Cancer Network, 2011
Chapter Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 188 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 189 Primary Chemotherapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 190 Early-Stage Disease . . . . . . . . . .
Robert J, Morgan, Ronald D, Alvarez, Deborah K, Armstrong, Barry, Boston, Robert A, Burger, Lee-May, Chen, Larry, Copeland, Marta Ann, Crispens, David, Gershenson, Heidi J, Gray, Perry W, Grigsby, Ardeshir, Hakam, Laura J, Havrilesky, Carolyn, Johnston, Shashikant, Lele, Ursula A, Matulonis, David M, O'Malley, Richard T, Penson, Steven W, Remmenga, Paul, Sabbatini, Russell J, Schilder, Julian C, Schink, Nelson, Teng, Theresa L, Werner   +23 more
  +5 more sources

Epithelial ovarian cancer [PDF]

The Lancet, 2019
Epithelial ovarian cancer generally presents at an advanced stage and is the most common cause of gynaecological cancer death. Treatment requires expert multidisciplinary care. Population-based screening has been ineffective, but new approaches for early diagnosis and prevention that leverage molecular genomics are in development.
S, Lheureux, Gourley, Charles, I, Vergote, AM, Oza   +3 more
openaire   +3 more sources

Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer: A matched cohort study.

PLoS ONE, 2022
IntroductionGermline BRCA1/2-associated epithelial ovarian cancer has been associated with better progression-free survival and overall survival than sporadic epithelial ovarian cancer, but conclusive data are lacking.MethodsWe matched 389 BRCA1 ...
Bernadette A M Heemskerk-Gerritsen, Antoinette Hollestelle, Christi J van Asperen, Irma van den Beek, Willemien J van Driel, Klaartje van Engelen, Encarna B Gómez Garcia, Joanne A de Hullu, Marco J Koudijs, Marian J E Mourits, Maartje J Hooning, Ingrid A Boere   +11 more
doaj   +1 more source

Preoperative Platelet-Lymphocyte Ratio as a Prognostic Factor of Epithelial Ovarian Cancer

Indonesian Journal of Obstetrics and Gynecology, 2023
Objective: To determine whether platelet-lymphocyte ratio can be a prognostic factor for epithelial ovarian cancer. Methods: This study was a retrospective cohort with analytical design, conducted in the Department of Obstetrics and Gynecology of Prof ...
Johan Winata, Bismarck Joel Laihad, Frank Mitchell Marvel Wagey   +2 more
doaj   +1 more source

Epithelial Ovarian Cancer

Obstetrics and Gynecology Clinics of North America, 2012
The incidence of epithelial ovarian cancer in women aged 40 years and younger is 3-17%. The management of these women is challenging and requires balancing the need to treat epithelial ovarian cancer adequately and preserving reproductive potential. Fertility-sparing surgery, especially for early stage epithelial ovarian cancer, seems to be associated ...
Ahmed N, Al-Niaimi, Mostafa, Ahmed, Chase B, Petersen   +2 more
  +7 more sources

Pentraxin 3 is a diagnostic and prognostic marker for ovarian epithelial cancer patients based on comprehensive bioinformatics and experiments

Cancer Cell International, 2021
Background Ovarian epithelial cancer is one of the leading malignant tumors in gynecology and lacks effective diagnostic and prognostic markers. Our study aims to screen and verify ovarian epithelial cancer biomarkers.
Xiaoying Chang, Dan Li, Chang Liu, Zhe Zhang, Tao Wang   +4 more
doaj   +1 more source

Treatment of epithelial ovarian cancer [PDF]

BMJ, 2020
ABSTRACTOvarian cancer is the third most common gynecologic malignancy worldwide but accounts for the highest mortality rate among these cancers. A stepwise approach to assessment, diagnosis, and treatment is vital to appropriate management of this disease process.
Kuroki, Lindsay, Guntupalli, Saketh R
openaire   +3 more sources

Focus on epithelial ovarian cancer [PDF]

Cancer Cell, 2004
Epithelial ovarian cancer (EOC) will be diagnosed in 24,400women in the United States in 2004, with an estimated 14,300deaths (Jemal et al., 2003).Neoplasms from the surface epithe-lium of the ovary exhibit a variety of Mullerian-type cells, includ-ing serous, mucinous, endometrioid, and clear cell, reflecting acommon pathway in embryological ...
Ozols, Robert F., Bookman, Michael A., Connolly, Denise C., Daly, Mary B., Godwin, Andrew K., Schilder, Russell J., Xu, Xiangxi, Hamilton, Thomas C.   +7 more
openaire   +2 more sources

Epidemiology of epithelial ovarian cancer [PDF]

Best Practice & Research Clinical Obstetrics & Gynaecology, 2017
Globally, ovarian cancer is the seventh most common cancer in women and the eighth most common cause of cancer death, with five-year survival rates below 45%. Although age-standardised rates are stable or falling in most high-income countries, they are rising in many low and middle income countries.
Penelope M. Webb, Susan J. Jordan
openaire   +4 more sources